You are here

Affibody

Acelyrin raises $250M, licenses antibody drug that could rival Novartis, Lilly meds

MedCity News

Tue, 11/16/21 - 10:31 am

monoclonal antibodies

Alexion adds to pipeline with two early-stage R&D deals

BioPharma Dive

Wed, 03/20/19 - 12:25 pm

Alexion Pharmaceuticals